Login / Signup
Buğra Öztosun
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Squamous Cell
Small Cell Lung Cancer
Free Survival
Ejection Fraction
Top Venues
Journal of chemotherapy (Florence, Italy)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Seval Ay
,
Muhammet Mustafa Atcı
,
Rukiye Arıkan
,
Ozgecan Dulgar
,
Deniz Tataroğlu Özyükseler
,
Nail Paksoy
,
Izzet Dogan
,
Buğra Öztosun
,
Didem Taştekin
,
Bala Başak Öven
,
Mahmut Gümüş
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.
Journal of chemotherapy (Florence, Italy)
34 (7) (2022)